Similar articles

• [Hepatic arterial infusion chemotherapy using totally implantable port system].

  Takayasu Y, Yamamoto S, Ikeda J. Takayasu Y, et al. Gan To Kagaku Ryoho. 2000 Sep;27(10):1516-20. Gan To Kagaku Ryoho. 2000. PMID: 11015995 Japanese.
• [Hepatic arterial infusion chemotherapy using 'low dose FP'].

  Nagamatsu H, Itano S, Sata M. Nagamatsu H, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:619-23. Nihon Rinsho. 2001. PMID: 11762023 Review. Japanese. No abstract available.
• [Adverse reaction of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].

  Tanaka M, Ando E, Itano S, Sata M. Tanaka M, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:640-4. Nihon Rinsho. 2001. PMID: 11762027 Review. Japanese. No abstract available.
• Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.

  Casanova M, Massimino M, Ferrari A, Spreafico F, Piva L, Coppa J, Luksch R, Cefalo G, Terenziani M, Polastri D, Bellani FF, Mazzaferro V. Casanova M, et al. Pediatr Hematol Oncol. 2005 Apr-May;22(3):189-98. doi: 10.1080/08880010590921441. Pediatr Hematol Oncol. 2005. PMID: 16020101 Clinical Trial.
• [A case with hepatocellular carcinoma effectively treated by continuous hepatic arterial infusion of etoposide, epirubicin and CDDP].

  Tarusawa K, Yodono H, Ikami I, Sasaki T, Kanehira J, Takahashi S, Shibutani K, Noda H, Shinohara A, Takekawa D. Tarusawa K, et al. Gan To Kagaku Ryoho. 1992 Mar;19(3):383-6. Gan To Kagaku Ryoho. 1992. PMID: 1311915 Japanese.